159 related articles for article (PubMed ID: 11032913)
21. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma.
Seremet S; Abhyankar S; Herd TJ; Aires D
J Drugs Dermatol; 2016 Oct; 15(10):1212-1216. PubMed ID: 27741338
[TBL] [Abstract][Full Text] [Related]
22. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
Zic J; Arzubiaga C; Salhany KE; Parker RA; Wilson D; Stricklin GP; Greer J; King LE
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):729-36. PubMed ID: 1430395
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H
Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455
[TBL] [Abstract][Full Text] [Related]
24. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
[No Abstract] [Full Text] [Related]
26. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
Stadler R; Otte HG
Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome.
Sanli H; Akay BN; Anadolu R; Ozcan M; Saral S; Akyol A
J Drugs Dermatol; 2011 Apr; 10(4):403-8. PubMed ID: 21455551
[TBL] [Abstract][Full Text] [Related]
28. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
[TBL] [Abstract][Full Text] [Related]
29. Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience.
Siakantaris MP; Tsirigotis P; Stavroyianni N; Argyropoulos KV; Girkas K; Pappa V; Chondropoulos S; Papadavid E; Sakellari I; Anagnostopoulos A; Antoniou C; Dervenoulas J
Transfus Apher Sci; 2012 Apr; 46(2):189-93. PubMed ID: 22178592
[TBL] [Abstract][Full Text] [Related]
30. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
[TBL] [Abstract][Full Text] [Related]
31. Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas.
de Masson A; Guitera P; Brice P; Moulonguet I; Mouly F; Bouaziz JD; Battistella M; Madelaine I; Roux J; Ram-Wolff C; Cayuela JM; Bachelez H; Bensussan A; Michel L; Bagot M
Br J Dermatol; 2014 Mar; 170(3):720-4. PubMed ID: 24438061
[TBL] [Abstract][Full Text] [Related]
32. Interferon in the treatment of cutaneous T-cell lymphoma.
Olsen EA
Dermatol Ther; 2003; 16(4):311-21. PubMed ID: 14686974
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
Prinz B; Behrens W; Hölzle E; Plewig G
Arch Dermatol Res; 1995; 287(7):621-6. PubMed ID: 8534123
[TBL] [Abstract][Full Text] [Related]
34. Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.
Rupoli S; Barulli S; Guiducci B; Offidani M; Mozzicafreddo G; Simonacci M; Filosa G; Giacchetti A; Ricotti G; Brandozzi G; Cataldi I; Serresi S; Ceschini R; Bugatti L; Offidani A; Giangiacomi M; Brancorsini D; Leoni P
Haematologica; 1999 Sep; 84(9):809-13. PubMed ID: 10477454
[TBL] [Abstract][Full Text] [Related]
35. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
[TBL] [Abstract][Full Text] [Related]
36. Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome.
Quereux G; Marques S; Nguyen JM; Bedane C; D'incan M; Dereure O; Puzenat E; Claudy A; Martin L; Joly P; Delaunay M; Beylot-Barry M; Vabres P; Celerier P; Sasolas B; Grange F; Khammari A; Dreno B
Arch Dermatol; 2008 Jun; 144(6):727-33. PubMed ID: 18559761
[TBL] [Abstract][Full Text] [Related]
37. Intramuscular low dose alpha-2B interferon and etretinate for treatment of mycosis fungoides.
Altomare GF; Capella GL; Pigatto PD; Finzi AF
Int J Dermatol; 1993 Feb; 32(2):138-41. PubMed ID: 8440560
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.
Hüsken AC; Tsianakas A; Hensen P; Nashan D; Loquai C; Beissert S; Luger TA; Sunderkötter C; Schiller M
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):71-8. PubMed ID: 22168776
[TBL] [Abstract][Full Text] [Related]
39. The treatment of cutaneous T-cell lymphoma with photopheresis.
Zic JA
Dermatol Ther; 2003; 16(4):337-46. PubMed ID: 14686977
[TBL] [Abstract][Full Text] [Related]
40. Combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Lemak NA; Redman JR; Eifel PJ; Tucker SL; Cabanillas FF; Kurzrock R
J Am Acad Dermatol; 1996 Jun; 34(6):1022-9. PubMed ID: 8647968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
